What's the Next Big Thing in the Prurigo Nodularis Treatment Market? Bayer AG, Pfizer Inc., GlaxoSmithKline Plc, Teva Pharmaceutical Industries Ltd, Johnson & Johnson
According to the latest report published by Future Market Insights titled 'Prurigo Nodularis Treatment Market: Global Industry Analysis 2013 – 2017 and Opportunity Assessment 2018 – 2028', the global prurigo nodularis treatment market is poised to expand at 3.4% CAGR over the forecast period of 2018–2028. The global market for prurigo nodularis treatment is expected to reach a valuation of US$ 697.9 Mn by 2028 end, attesting the highest growth rate by Middle East & Africa, which is expected to...
View full press release